GENSCO PHARMA RETAIL PHARMACY VOUCHER PROGRAMS
Need help with prescription costs? Save the the Affordable Medication Solutions RX Savings Cards
2x15mL: NDC 35781-0400-2
30mL: NDC 35781-2500-3
10mL: NDC 3 5781-0300-1
30mL: NDC 35781-0300-3
90mL: NDC 35781-0300-9
10mL: NDC 35781-0210-1
30mL: NDC 35781-0210-2
90mL: NDC 35781-0210-9
Reduce Your Gout Pain
“At the Site” and In Your Pocket
Gensco® introduces the innovative ColciGel-Allopurinol Voucher Program offering affordable access to ColciGel® for acute gout flares and Allopurinol for the management of uric acid levels.
For more information, click here.
PARTICIPATING PHARMACIES
LOOKING TO THE FUTURE
A single dose topical colchinium for acute gout flares.
A single dose topical anesthetic for injections and vaccines.
EASY STEPS FOR PATIENT SAVINGS THROUGH YOUR PHARMACY
The process to become a credentialed Affordable Medication Solutions RetainRx® In-Network Provider for Gensco Copay Programs is easy.
GENSCO® TRENDING
Physician Explores Gout Treatment Options May 15, 2017 Articles, Clinical, Featured - As seen in Chain Drug Review | May 15, 2017 MIAMI — Gout is an extremely painful form of inflammatory arthritis and the more...Looking To The Future
- Protected: Topical vs Transdermal Lidocaine June 21, 2017 Clinical - Prescription Product Comparison for Intact Skin Product 5% Lidocaine Ointment[1] Lidocaine Patch[2] LiDORx[3] Delivery more...
- Physician Explores Gout Treatment Options May 15, 2017 Articles, Clinical, Featured - As seen in Chain Drug Review | May 15, 2017 MIAMI — Gout is an extremely painful form more...
- The Difference Between Topical and Transdermal Medications March 29, 2017 Clinical, Research - White Paper by Robert L. Wilbur, Pharm.D., CPh | Executive Director, Medical Affairs, Gensco Pharma Abstract more...
- Working In All Disease States and Cost Management Areas to Help Patients Access Medications March 21, 2017 Clinical, Featured, Industry - Gensco® President and CEO, Carlos Alfaras, recently moderated a Thought Interaction Pod (TIP) session at more...